CV Technologies, the Alberta based manufacturer of
Cold-fx is emerging as one of those 'instant' 10 year success stories. The company recently held its annual meeting in Edmonton and probably got more notoriety for its master Promoter
Don Cherry than for the accomplishment embedded in its
business plan. However the plan and track record are worth a hard look. The company has embraced the current
prove it regulatory culture and is emerging as a leader in " developing
evidence-based natural therapeutics for disease prevention and health maintenance"
The company has a
'pipeline of products' and perhaps more importantly a research technology that took $15 million, and a decade to perfect. Going forward that process, known as
ChemBioPrint technology may be more valuable than the product line. Chem Bio Print is a proprietary tool that allows the company to meet evidential standards demanded by regulators. It could very well be the catalyst to a dominant position in the market place.
No comments:
Post a Comment